Commercialisation

Commercialisation is the process of introducing a new product or production method into the market.

At Strathclyde, we’ve a long and successful history of commercialisation of the inventions and business innovations made by our staff. This is done in two ways: the licensing of our Intellectual Property Rights (IPRs) to global companies and the formation of spin-out and start-up companies.

Licensing

We're one of the UK’s top 10 institutions for licence royalty income, based on our researchers’ innovations and discoveries. The University has cumulative royalty income of £42 million and our current IPR portfolio includes around 100 licensing opportunities.

View our current technologies available for licensing. These opportunities have emerged from Strathclyde research.

Licensing examples

Licensing of University-owned technology to TreeGreen

Brian O’Reilly, a University of Strathclyde Enterprise Fellow, developed the Energy Egg, a unique energy saving device that could save households hundreds of pounds a year.

A new company, Tree Green Ltd, was formed to commercialise the product.

The Energy Egg received research and development support from Strathclyde’s Department of Electronic and Electrical Engineering and is now being sold on Tesco Direct.

Strathclyde is a partner in the product and licensor of part of the technology. Scottish Enterprise and The Royal Society of Edinburgh provided additional grants and advice.

Formation of MGB Biopharma

MGB Biopharma Ltd, a biopharmaceutical company, was started based on a licence to Strathclyde-owned intellectual property to develop a new class of anti-infective medicines based upon compounds which are DNA Minor Groove Binders.

It was shortlisted for the Nexxus Scotland Life Sciences Awards 2010 in the ‘Most Promising Young Life Sciences Company of the Year (West) category.

MGB Biopharma’s first funding round of £2 million was led by Archangel Informal Investments Ltd.

Spin-out companies

Strathclyde has formed over 50 spin-out companies, making annual sales of £80 million and employing more than 700 people, mostly in our home region of the West of Scotland.

We support the development of spin-out companies through the Executive Directors Designate Programme (EDDP).

The EDDP was set up by the University to:

  • increase the number of spin-out companies
  • improve the chances of raising seed funding for these spin-out companies´╗┐
  • in the longer term, improve chances of returns for shareholders in these companies, including the University

Our programme allows us to pay consultancy fees of individuals sourced from outside the University or buy out the time of academics, to allow them to focus on spinning-out these companies.

EDDP is funded by the European Regional Development Fund and is available for use by all Scottish universities.

Discover more about Nautricity, one of our successful spin-out companies, which licensed our revolutionary tidal turbine technology, or find more information on a range of Strathclyde spin-out companies.